Assignee
ASCENT PHARMA INC
US·8 granted patents·4 pending applications·149 citations·filing 1995–2019
Top patents by PatentIndex Score
12 records- 0176US5672358AControlled release aqueous emulsionASCENT PHARMA INC·Filed 1995·Granted Sep 30, 1997·56 cites·23 claims
- 0267US5576346AProcess for treating uremic pruritusASCENT PHARMA INC·Filed 1995·Granted Nov 19, 1996·34 cites·11 claims
- 0360US5455049ATerfenadine oral powderASCENT PHARMA INC·Filed 1995·Granted Oct 3, 1995·20 cites·8 claims
- 0457US5552436AProcess for treating hemangiomaASCENT PHARMA INC·Filed 1995·Granted Sep 3, 1996·21 cites·11 claims
- 0549US5626879ATerfenadine oral granulesASCENT PHARMA INC·Filed 1995·Granted May 6, 1997·11 cites·20 claims
- 0643US5532270AComposition and process for prevention and treatment of cutaneous immediate hypersensitivity reactionsASCENT PHARMA INC·Filed 1995·Granted Jul 2, 1996·6 cites·5 claims
- 0738US2021015776A1Methods of stabilization of levothyroxine sodium tabletsASCENT PHARMA INC·Filed 2019·Application pending·0 cites
- 0832US5684038AComposition and process for prevention and treatment of cutaneous immediate hypersensitivity reactionsASCENT PHARMA INC·Filed 1996·Granted Nov 4, 1997·1 cites·5 claims
- 0932US2018169061A1Non-aqueous delta9-tetrahydrocannabinol oral liquid formulationsASCENT PHARMA INC·Filed 2017·Application pending·0 cites
- 1030US2017304150A1Stable packaging system for moisture and oxygen sensitive pharmaceutical dosage formsASCENT PHARMA INC·Filed 2017·Application pending·0 cites
- 1129US5684037AComposition and process for prevention and treatment of cutaneous immediate hypersensitivity reactionsASCENT PHARMA INC·Filed 1996·Granted Nov 4, 1997·0 cites·6 claims
- 1228US2017312226A1Pharmaceutical dosage formsASCENT PHARMA INC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →